These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3525706)

  • 1. VP-16: phase specific cytocidal activity and preliminary trials in acute monocytic leukemias.
    Izumi Y; Okazaki T; Mochizuki T; Ishikura H; Tashima M; Sasada M; Sawada H; Uchino H
    Nihon Gan Chiryo Gakkai Shi; 1986 Apr; 21(3):591-600. PubMed ID: 3525706
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute monocytic and myelomonocytic leukemias. Incidence and treatment with an epipodophyllotoxin derivative (VP 16.213)].
    Bernasconi C; Lazzarino M; Morra E
    Recenti Prog Med; 1975 Oct; 59(4):372-87. PubMed ID: 769106
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acute monocytic leukemia and acute myelomonocytic leukemia: treatment using VP 16213].
    Amiel JL; Schwarzenberg L; Musset M; De Vassal F; Hayat M; Mathé G
    Bull Cancer; 1974; 61(3):419-26. PubMed ID: 4533742
    [No Abstract]   [Full Text] [Related]  

  • 4. [Initial results with a epipodophyllotoxin derivative VP 16-213 in the treatment of acute leukemia].
    Cavalli F; Ryssel HJ; Batz K; Sonntag RW; Brunner KW
    Schweiz Med Wochenschr; 1975 Feb; 105(8):250-3. PubMed ID: 1054886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute leukemia and various hematosarcomas. Trial treatment with a second derivative of podophyllotoxin (4-demethyl-epipodophyllotoxin beta D ethylidene glucoside VP 16213 or EPE)].
    Mathé G; Schwarzenberg L; Pouillart P; Weiner R; Oldham R; Jasmin C; Rosenfeld C; Hayat M; Schneider M; Amiel JL; Céoara B; Steresco-Musset M; de Vassal F
    Nouv Presse Med; 1974 Mar; 3(9):521-4. PubMed ID: 4595555
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of VP-16 on cell growth and metabolism of nucleic acids in mouse leukemia L-1210 cells and on the activity of DNA polymerase I of E. coli.
    Izumi Y; Usui T; Okazaki T; Mochizuki T; Ishikura H; Tashima M; Sawada H; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1985 Sep; 48(6):1371-80. PubMed ID: 3911717
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical and animal experiment studies on the cell-cycle arrest using cytosine arabinoside in leukemias].
    Büchner T; Barlogie B; Hiddemann W; Hofschröer J; Metz U; Ortheil NB; Kamanabroo D; Asseburg U
    Verh Dtsch Ges Inn Med; 1975; 81():1112-4. PubMed ID: 1065151
    [No Abstract]   [Full Text] [Related]  

  • 8. Action of free radical in podophyllic acid piperindyl hydrazone nitroxide radical on its antitumor activity and toxicity.
    Jia ZP; Wang R; Xie JW; Xu LT
    Zhongguo Yao Li Xue Bao; 1999 Jun; 20(6):571-6. PubMed ID: 10678157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VP 16-213 and cyclophosphamide in the treatment of refractory acute nonlymphocytic leukemia with monocytic features.
    Hurd DD; Peterson BA; McKenna RW; Bloomfield CD
    Med Pediatr Oncol; 1981; 9(3):251-5. PubMed ID: 7017368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokinetic analysis of L1210 leukemia after continuous infusion of hydroxyurea in vivo.
    Moran RE; Straus MJ
    Cancer Res; 1979 May; 39(5):1616-22. PubMed ID: 427801
    [No Abstract]   [Full Text] [Related]  

  • 11. [Synthesis of spin labeled analogue of podophyllotoxin glycoside].
    Lu K; Chen Y
    Yao Xue Xue Bao; 1998 Dec; 33(12):948-50. PubMed ID: 12016863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-characteristic response of L1210 cells to lovastatin.
    Engelke KJ; Hacker MP
    Biochem Biophys Res Commun; 1994 Aug; 203(1):400-7. PubMed ID: 8074684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the epipodophyllotoxin VP-16-213 on cell cycle traverse, DNA synthesis, and DNA strand size in cultures of human leukemic lymphoblasts.
    Kalwinsky DK; Look AT; Ducore J; Fridland A
    Cancer Res; 1983 Apr; 43(4):1592-7. PubMed ID: 6572554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia.
    Felix CA; Winick NJ; Negrini M; Bowman WP; Croce CM; Lange BJ
    Cancer Res; 1993 Jul; 53(13):2954-6. PubMed ID: 8319201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pharmacological studies with 5-hydroxy-2-formylpyridine thiosemicarbazone.
    DeConti RC; Toftness BR; Agrawal KC; Tomchick R; Mead JA; Bertino JR; Sartorelli AC; Creasey WA
    Cancer Res; 1972 Jul; 32(7):1455-62. PubMed ID: 4555384
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytotoxic effects of dexamethasone restricted to noncycling, early G1-phase cells of L1210 leukemia.
    Smets LA; Bout B; Brouwer M; Tulp A
    J Cell Physiol; 1983 Sep; 116(3):397-403. PubMed ID: 6885934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemia.
    Dombernowsky P; Nissen NI
    Acta Pathol Microbiol Scand A; 1973 Sep; 81(5):715-24. PubMed ID: 4771975
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of diazane on the mitotic cycle of transplantable leukemia LA in mice].
    Goncharova SA; Konovalova NP; Shevtsova VN
    Vopr Onkol; 1980; 26(6):59-63. PubMed ID: 7385731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of etoposide-induced DNA damage by calcium antagonists in L1210 cells in vitro.
    Yalowich JC; Ross WE
    Cancer Res; 1984 Aug; 44(8):3360-5. PubMed ID: 6744270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proliferation kinetics of human leukemic blasts, with a special reference to labelling index of 3H-TdR and DNA synthesis time].
    Moteki M
    Nihon Ketsueki Gakkai Zasshi; 1977 Jun; 40(3):284-92. PubMed ID: 270269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.